Pharvaris
Business Services · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Grafenauweg 8, Zug, Zug, 6300, Switzerla...Phone Number
+31 712036410Website
www.pharvaris.comRevenue
$104.2 MillionStock Symbol
PHVSIndustry
ZI Rank: 1
About Pharvaris
Pharvaris Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharvaris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pharvaris launches new products
Click to see if Pharvaris had a recent Job posting/layoffs
Earning: See what the market has to say on Pharvaris recently announced quarterly report
Funding: Get notified immidiatlly once Pharvaris has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pharvaris
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Pharvaris, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Pharvaris is spiking on competitors!
Check if Pharvaris has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Pharvaris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pharvaris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pharvaris.
Pharvaris financials insights
Gather financial insights about Pharvaris, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$18.3M
Series B
$66M
Series C
$80M
Stock/Share Issuance
$201M
Pharvaris Tech Stack
A closer look at the technologies used by Pharvaris
Most Recent Scoops
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharvaris
Pharvaris is a clinical-stage biopharmaceutical company founded in 2015 that develops oral B2-receptor antagonists as therapeutic alternatives to injected treatments. The company focuses on creating novel small molecules for hereditary angioedema (HAE) and other B2-receptor-mediated conditions. Based in the Netherlands with additional operations in... Read More
